TLR3 deficiency induces chronic inflammatory cardiomyopathy in resistant mice following coxsackievirus B3 infection: Role for IL-4

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 304, Issue 4, 2013, Pages

  Abston, Eric D ^a   Coronado, Michael J ^a   Bucek, Adriana ^a   Onyimba, Jennifer A ^a   Brandt, Jessica E ^a   Augusto Frisancho, J ^a   Kim, Eunyong ^a   Bedja, Djahida ^b   Sung, Yoon Kyu ^a   Radtke, Andrea J ^b   Gabrielson, Kathleen L ^a,b   Mitzner, Wayne ^a   Fairweather, DeLisa ^a,b  

^a The Johns Hopkins University   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Inflammation; Innate immunity; Myocarditis; Viral

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; TOLL LIKE RECEPTOR 3; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CHRONIC DISEASE; CONTROLLED STUDY; COXSACKIE VIRUS B3; COXSACKIE VIRUS INFECTION; DISEASE COURSE; ECHOCARDIOGRAPHY; HEART FUNCTION; HEMODYNAMIC MONITORING; IN VIVO STUDY; INFLAMMATORY DILATED CARDIOMYOPATHY; MACROPHAGE; MALE; MOUSE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH2 CELL; VIRUS REPLICATION;

ACUTE DISEASE; ANIMALS; CARDIOMYOPATHY, DILATED; CHRONIC DISEASE; COXSACKIEVIRUS INFECTIONS; CYTOKINES; DISEASE MODELS, ANIMAL; ENTEROVIRUS B, HUMAN; HUMANS; INTERLEUKIN-4; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MYOCARDITIS; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTOR 3; VIRUS REPLICATION;

EID: 84874070768     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00516.2011     Document Type: Article

References (59)

1. Abston ED, Coronado MJ, Bucek A, Bedja D, Shin J, Kim JB, Kim E, Gabrielson KL, Georgakopoulos D, Mitzner W, Fairweather D. Th2 regulation of viral myocarditis in mice: different roles for TLR3 vs. TRIF in progression to chronic disease. Clin Dev Immunol 2012: 129486, 2012.
2. Abston ED, Barin JG, Cihakova D, Bucek A, Coronado MJ, Brandt JE, Bedja D, Kim JB, Georgakopoulos D, Gabrielson KL, Mitzner W, Fairweather D. IL-33 independently induces eosinophilic pericarditis and cardiac dilation: ST2 improves cardiac function. Circ Heart Fail 5: 366-375, 2012.
3. Afanasyeva M, Wang Y, Kaya Z, Park S, Zilliox MJ, Schofield BH, Hill SL, Rose NR. Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am J Pathol 159: 193-203, 2001.
4. Afanasyeva M, Georgakopoulos D, Fairweather D, Caturegli P, Kass DA, Rose NR. A novel model of constrictive pericarditis associated with autoimmune heart disease in interferon-γ knockout mice. Circulation 110: 2910-2917, 2004.
5. Afanasyeva M, Georgakopoulos D, Belardi DF, Bedja D, Fairweather D, Wang Y, Kaya Z, Gabrielson KL, Rodriguez ER, Caturegli P, Kass DA, Rose NR. Impaired up-regulation of CD25 on CD4+ T cells in IFN-γ knockout mice is associated with progression of myocarditis to heart failure. Proc Natl Acad Sci USA 102: 180-185, 2005.
6. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413: 732-738, 2001.
7. Baldeviano GC, Barin JG, Talor MV, Srinivasan S, Bedja D, Zheng D, Gabrielson K, Iwakura Y, Rose NR, Cihakova D. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circ Res 106: 1646-1655, 2010.
8. Barin JG, Talor MV, Baldeviano GC, Kimura M, Rose NR, Cihakova D. Mechanisms of IFN-γ regulation of autoimmune myocarditis. Exp Mol Pathol 89: 83-91, 2010.
9. Blauwet LA, Cooper LT. Myocarditis. Prog Cardiovasc Dis 52: 274-288, 2010.
10. Chow LH, Gauntt CJ, McManus BM. Differential effects of myocarditic variants of coxsackievirus B3 in inbred mice. A pathologic characterization of heart tissue damage. Lab Invest 64: 55-64, 1991.
11. Cihakova D, Barin JG, Afanasyeva M, Kimura M, Fairweather D, Berg M, Talor MV, Baldeviano GC, Frisancho-Kiss S, Gabrielson K, Bedja D, Rose NR. Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation. Am J Pathol 172: 1195-1208, 2008.
12. Cooper LT Jr. Myocarditis. N Engl J Med 360: 1526-1538, 2009.
13. Coronado MJ, Brandt JE, Kim E, Bucek A, Bedja D, Abston ED, Shin J, Gabrielson KL, Mitzner W, Fairweather D. Testosterone and interleukin-1β increase cardiac remodeling during acute coxsackievirus B3 myocarditis via serpin A 3n. Am J Physiol Heart Circ Physiol 302: H1726-H1736, 2012.
14. + myeloid cells. J Immunol 185: 1383-1392, 2010.
15. Edelmann KH, Richardson-Burns S, Alexopoulou L, Tyler KL, Flavell RA, Oldstone MB. Does Toll-like receptor 3 play a biologic role in virus infections? Virology 322: 231-238, 2004.
16. Fairweather D, Yusung S, Frisancho S, Barrett M, Gatewood S, Steele R, Rose NR. IL-12Rβ1 and TLR4 increase IL-1β and IL-18-associated myocarditis and coxsackievirus replication. J Immunol 170: 4731-4737, 2003.
17. Fairweather D, Frisancho-Kiss S, Gatewood S, Njoku D, Steele R, Barrett M, Rose NR. Mast cells and innate cytokines are associated with susceptibility to autoimmune heart disease following coxsackievirus B3 infection. Autoimmunity 37: 131-145, 2004.
18. Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Gatewood SJL, Davis SE, Njoku NB, Rose NR. IFN-γ protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines TGF-β, IL-1β, and IL-4 in the heart. Am J Pathol 165: 1883-1894, 2004.
19. Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Davis SE, Steele RA, Gatewood SJL, Rose NR. IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-γ and macrophage and neutrophil populations in the heart. J Immunol 174: 261-269, 2005.
20. Fairweather D, Rose NR. Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods 41: 118-122, 2007.
21. Fairweather D, Cihakova D. Alternatively activated macrophages in infection and autoimmunity. J Autoimmun 33: 222-230, 2009.
22. Fairweather D, Stafford KA, Sung YK. Update on coxsackievirus B3 myocarditis. Curr Opin Rheumatol 24: 401-407, 2012.
23. Fan Y, Weifeng W, Yluan Y, Qing K, Yu P, Yanlan H. Treatment with neutralizing anti-murine interleukin-17 antibody after onset of coxsackievirus B3-induced viral myocarditis reduces myocardium inflammation. Virol J 8: 17, 2011.
24. Frisancho-Kiss S, Nyland JF, Davis SE, Barrett MA, Gatewood SJL, Njoku DB, Cihakova D, Silbergeld EK, Rose NR, Fairweather D. Cutting Edge: T cell Ig mucin-3 reduces inflammatory heart disease by increasing CTLA-4 during innate immunity. J Immunol 176: 6411-6415, 2006.
25. Frisancho-Kiss S, Nyland JF, Davis SE, Frisancho JA, Barrett MA, Rose NR, Fairweather D. Sex differences in coxsackievirus B3-induced myocarditis: IL-12Rβ1 signaling and IFN-γ increase inflammation in males independent from STAT4. Brain Res 1126: 139-147, 2006.
26. Frisancho-Kiss S, Davis SE, Nyland JF, Frisancho JA, Cihakova D, Rose NR, Fairweather D. Cutting Edge: Cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease. J Immunol 178: 6710-6714, 2007.
27. + T cells, Th2 cells and Treg in the heart during acute coxsackievirus-induced myocarditis. Brain Behav Immun 23: 649-657, 2009.
28. Fuse K, Kodama M, Aizawa Y, Yamaura M, Tanabe Y, Takahashi K, Sakai K, Miida T, Oda H, Higuma N. Th1/Th2 balance alteration in the clinical course of a patient with acute viral myocarditis. Jpn Circ J 65: 1082-1084, 2001.
29. Georgakopoulos D, Kass DA. Protocols for hemodynamic assessment of transgenic mice in vivo. Methods Mol Biol 219: 233-243, 2003.
30. Gorbea C, Maker KA, Pauschinger M, Pratt G, Bersola JL, Varela J, David RM, Banks L, Huang CH, Li H, Schultheiss HP, Towbin JA, Vallejo JG, Bowles NE. A role for Toll-like receptor 3 variants in host susceptibility to entorviral myocarditis and dilated cardiomyopathy. J Biol Chem 285: 23208-23223, 2010.
31. Hardarson HS, Baker JS, Yang Z, Purevjav E, Huang CH, Alexopoulou L, Li N, Flavell RA, Bowles NE, Vallejo JG. Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury. Am J Physiol Heart Circ Physiol 292: H251-H258, 2007.
32. Hedayat M, Mahmoudi MJ, Rose NR, Rezaei N. Proinflammatory cytokines in heart failure: double-edged swords. Heart Fail Rev 15: 543-562, 2010.
33. Huber S, Shi C, Budd RC. Gammadelta T cells promote a Th1 response during coxsackievirus B3 infection in vivo: role of Fas and Fas ligand. J Virol 76: 6487-6494, 2002.
34. Jiang Z, Xu W, Li K, Yue Y, Xu L, Ye F, Xiong S. Remission of CVB3-induced viral myocarditis by in vivo Th2 polarization via hydrodynamics-based interleukin-4 gene transfer. J Gene Med 10: 918-929, 2008.
35. Kallwellis-Opara A, Dorner A, Poller WC, Noutsias M, Kuhl U, Schultheiss HP, Pauschinger M. Autoimmunological features in inflammatory cardiomyopathy. Clin Res Cardiol 96: 469-480, 2007.
36. Kania G, Blyszczuk P, Eriksson U. Mechanisms of cardiac fibrosis in inflammatory heart disease. Trends Cardiovasc Med 19: 247-252, 2009.
37. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11: 373-384, 2010.
38. Kuethe F, Braun RK, Foerster M, Schlenker Y, Sigusch HH, Kroegel C, Figulla HR. Immunopathogenesis of dilated cardiomyopathy. Evidence for the role of Th2-type CD4+ T lymphocytes and association with myocardial HLA-DR expression. J Clin Immunol 26: 33-39, 2006.
39. Kuhl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M, Poller W, Schultheiss HP. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107: 2793-2798, 2003.
40. Kumar V, Abbas AK, Fausto N. Tissue renewal and repair: regeneration, healing and fibrosis. In: Robbins and Cotran Pathologic Basis of Disease, 7th ed., Philadelphia, Elsevier Saunders, 2005, p. 87-118.
41. Li J, Leschka S, Rutschow S, Schwimmbeck PL, Husmann L, Noutsias M, Westermann D, Poller W, Zeichhardt H, Klingel K, Tschope C, Schultheiss HP, Pauschinger M. Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditis. Eur J Pharmacol 554: 60-68, 2007.
42. Li Y, Heuser JS, Kosanke SD, Hemric M, Cunningham MW. Protection against experimental autoimmune myocarditis is mediated by interleukin-10-producing T cells that are controlled by dendritic cells. Am J Pathol 167: 5-15, 2005.
43. Looi JL, Edwards C, Armstrong GP, Scott A, Patel H, Hart H, Christiansen JP. Characteristics and prognostic importance of myocardial fibrosis in patients with dilated cardiomyopathy assessed by contrastenhanced cardiac magnetic resonance imaging. Clin Med Insights Cardiol 4: 129-134, 2010.
44. Maisch B, Richter A, Sandmoller A, Portig I, Pankuweit S, on behalf of the Heart Failure Network. Inflammatory dilated cardiomyopathy. Herz 30: 535-544, 2005.
45. Mamas MA, Fraser D, Neyses L. Cardiovascular manifestations associated with influenza virus infection. Int J Cardiol 130: 304-309, 2008.
46. Negishi H, Osawa T, Ogami K, Ouyang X, Sakaguchi S, Koshiba R, Yanai H, Seko Y, Shitara H, Bishop K, Yonekawa H, Tamura T, Kaisho T, Taya C, Taniguchi T, Honda K. A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proc Natl Acad Sci USA 105: 20446-20451, 2008.
47. Onyimba JA, Coronado MJ, Garton AE, Kim JB, Bucek A, Bedja D, Gabrielson KL, Guilarte TR, Fairweather D. The innate immune response to coxsackievirus B3 predicts progression to cardiovascular disease and heart failure in male mice. Biol Sex Differ 2: 2, 2011.
48. Pacher P, Nagayama T, Mukhopadhyay P, Batkai S, Kass DA. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protocols 3: 1422-1434, 2008.
49. Pagni PP, Traub S, Demaria O, Chasson L, Alexopoulou L. Contribution of TLR7 and TLR9 signaling to the susceptibility of MyD88-deficient mice to myocarditis. Autoimmunity 43: 275-287, 2010.
50. Pan HY, Yano M, Kido H. Effects of inhibitors of Toll-like receptors, protease-activated receptor-2 signalings and trypsin on influenza A virus replication and upregulation of cellular factors in cardiomyocytes. J Med Invest 58: 19-28, 2011.
51. Rezkalla SH, Kloner RA. Influenza-related viral myocarditis. Wisconsin Med J 109: 209-213, 2010.
52. Richer MJ, Lavallee DJ, Shanina I, Horwitz MS. Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection. PLoS One 4: e4127, 2009.
53. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Hait JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics Committee, and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 125: e2-e220, 2012.
54. Satoskar AR, Elizondo J, Menteforte GM, Stamm LM, Bluethmann H, Katavolos P, Telford 3rd SR. Interleukin-4-deficient BALB/c mice develop an inhanced Th1-like response but control cardiac inflammation following Borrelia burgdorferi infection. FEMS Microbiol Lett 183: 319-325, 2000.
55. Shi Y, Fukuoka M, Li G, Liu Y, Chen M, Konviser M, Chen X, Opavsky MA, Liu PP. Regulatory T cells protect mice against coxsackievirus-induced myocarditis through the transforming growth factor-coxsackie-adenovirus receptor pathway. Circulation 121: 2624-2634, 2010.
56. Triantafilou K, Orthopoulos G, Vakakis E, Ahmed MAE, Golenbock DT, Lepper PM, Triantafilou M. Human cardiac inflammatory responses triggered by coxsackie B viruses are mainly Toll-like receptor (TLR) 8-dependent. Cell Microbiol 7: 1117-1126, 2005.
57. Wang YX, da Cunha V, Vincelette J, White K, Velichko S, Xu Y, Gross C, Fitch RM, Halks-Miller M, Larsen BR, Yajima T, Knowlton KU, Vergona R, Sullivan ME, Croze E. Antiviral and myocyte protective effects of murine interferon-β and-α2 in coxsackievirus B3-induced myocarditis and epicarditis in BALB/c mice. Am J Physiol Heart Circ Physiol 293: H69-H76, 2007.
58. Weinzierl AO, Szalay G, Wolburg H, Sauter M, Rammensee HG, Kandolf R, Stevanovic S, Klingel K. Effective chemokine secretion by dendritic cells and expansion of cross-presenting CD4-/CD8+ dendritic cells define a protective phenotype in the mouse model of coxsackievirus myocarditis. J Virol 82: 8149-8160, 2008.
59. Wexler RK, Elton T, Pleister A, Feldman D. Cardiomyopathy: an overview. Am Fam Physician 79: 778-784, 2009.